BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12869573)

  • 1. Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase.
    Lee MH; Rapti M; Murphy G
    J Biol Chem; 2003 Oct; 278(41):40224-30. PubMed ID: 12869573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
    Lee MH; Rapti M; Knaüper V; Murphy G
    J Biol Chem; 2004 Apr; 279(17):17562-9. PubMed ID: 14734567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
    Lee MH; Rapti M; Murphy G
    J Biol Chem; 2004 Oct; 279(43):45121-9. PubMed ID: 15308656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment.
    Lee MH; Atkinson S; Rapti M; Handsley M; Curry V; Edwards D; Murphy G
    Cancer Lett; 2010 Apr; 290(1):114-22. PubMed ID: 19815335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
    Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R
    J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
    Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation.
    Määttä M; Soini Y; Liakka A; Autio-Harmainen H
    Am J Clin Pathol; 2000 Sep; 114(3):402-11. PubMed ID: 10989641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
    EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs).
    Lafleur MA; Handsley MM; Knäuper V; Murphy G; Edwards DR
    J Cell Sci; 2002 Sep; 115(Pt 17):3427-38. PubMed ID: 12154073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
    Hamze AB; Wei S; Bahudhanapati H; Kota S; Acharya KR; Brew K
    Protein Sci; 2007 Sep; 16(9):1905-13. PubMed ID: 17660250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting a Designer TIMP-1 to the Cell Surface for Effective MT1-MMP Inhibition: A Potential Role for the Prion Protein in Renal Carcinoma Therapy.
    Jiang B; Liu J; Lee MH
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A.
    Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
    J Biol Chem; 1998 Dec; 273(52):34745-52. PubMed ID: 9856998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of membrane type 1 metalloproteinase (MT1-MMP) in reactive astrocytes following neurodegeneration in mouse central nervous system.
    Rathke-Hartlieb S; Budde P; Ewert S; Schlomann U; Staege MS; Jockusch H; Bartsch JW; Frey J
    FEBS Lett; 2000 Sep; 481(3):227-34. PubMed ID: 11007969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into MMP-TIMP interactions.
    Bode W; Fernandez-Catalan C; Grams F; Gomis-Rüth FX; Nagase H; Tschesche H; Maskos K
    Ann N Y Acad Sci; 1999 Jun; 878():73-91. PubMed ID: 10415721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2.
    Toth M; Bernardo MM; Gervasi DC; Soloway PD; Wang Z; Bigg HF; Overall CM; DeClerck YA; Tschesche H; Cher ML; Brown S; Mobashery S; Fridman R
    J Biol Chem; 2000 Dec; 275(52):41415-23. PubMed ID: 10998420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
    Wei S; Chen Y; Chung L; Nagase H; Brew K
    J Biol Chem; 2003 Mar; 278(11):9831-4. PubMed ID: 12515831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.